Arca Biopharma (ABIO) has released an update to notify the public and investors about its officers.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Raymond L. Woosley and Dan Mitchell have stepped down from ARCA biopharma’s board of directors, leading to an immediate reduction in the board size from eight to six members. Their resignations were amicable, with no disagreements cited regarding the company’s operations or policies. ARCA has acknowledged their valuable contributions during their tenure on the board.
For further insights into ABIO corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
